Determine the Safety and Dose of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A
Status:
Recruiting
Trial end date:
2027-08-19
Target enrollment:
Participant gender:
Summary
Open-label, Dose-escalation, Phase 1 Clinical Trial to Determine the Safety and Dose of EN001
in Patients with Charcot-Marie-Tooth disease (CMT) type 1A